F.D.A. Approves New Nasal Spray for Migraines

F.D.A. Approves New Nasal Spray for Migraines

The New York Times - Business:

Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.

This post first appeared in The New York Times - Business. Read the original article.